SEATTLE TECH

Seattle Biotech News

Fred Hutch Joins CERo Therapeutics Clinical Trial

Fred Hutch Joins CERo Therapeutics Clinical Trial

The Seattle center joins a Phase 1 study testing the safety of the experimental CER-1236 therapy for blood cancers.

Live Poll

Is the pace of progress in developing new cancer treatments improving in your country?


Recent news